Literature DB >> 1593670

Renal revascularization to preserve and restore renal function.

J A Libertino1, P J Bosco, C Y Ying, D J Breslin, B O Woods, N P Tsapatsaris, N W Swinton.   

Abstract

A total of 97 patients underwent 107 renal revascularization procedures for restoration and preservation of renal function. Of the 4 groups of high risk surgical patients that emerged an overall successful outcome was achieved in 83%, with a 6% mortality rate and an 11% morbidity rate. Renal revascularization for restoration and preservation of renal function can be performed safely with good results. The preoperative serum creatinine level was not predictive of the surgical outcome. Alternative bypass procedures are preferred.

Entities:  

Mesh:

Year:  1992        PMID: 1593670     DOI: 10.1016/s0022-5347(17)37603-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Stent revascularization for atherosclerotic renal artery stenosis. 1-year clinical follow-up.

Authors:  G Dorros; M R Jaff; L Mathiak; I I Dorros; A Lowe; K Murphy; T He
Journal:  Tex Heart Inst J       Date:  1998

2.  Atherosclerotic Renal Artery Stenosis.

Authors:  Robert D. Safian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

Review 3.  Atherosclerotic renal artery stenosis: from diagnosis to treatment.

Authors:  P Carmichael; A R Carmichael
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

Review 4.  An update on renovascular hypertension.

Authors:  Martin Senitko; Andrew Z Fenves
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

5.  The current state of endovascular therapy in the evaluation and management of renovascular disease.

Authors:  Praveen R Anchala; Scott A Resnick
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

Review 6.  The diagnosis and management of renovascular disease: a primary care perspective. Part II. Issues in management.

Authors:  Michael J Bloch; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.